Clinical Trial Update: Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries

View source ↗

Summary

A retrospective chart review study assessing characteristics, treatment outcomes, and resource use for adults hospitalized with community-acquired pneumonia and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Complicated Skin and Soft Tissue Infection

Drugs mentioned

• Zinforo (ceftaroline fosamil)

Snippet

Sponsor: Pfizer | Conditions: Community Acquired Pneumonia, Complicated Skin and Soft Tissue Infection | Status: COMPLETED | Results posted: 2024-03-26